ID

39317

Beschreibung

Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01476787

Link

https://clinicaltrials.gov/show/NCT01476787

Stichworte

Versionen (1)
  1. 19.12.19 19.12.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

19. Dezember 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Follicular Lymphoma NCT01476787

Englisch

Eligibility Follicular Lymphoma NCT01476787

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed follicular lymphoma grade 1, 2 or 3a, stage ii-iv
Beschreibung

Follicular Lymphoma Grade | Follicular Lymphoma Ann Arbor lymphoma staging system

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0441800
UMLS CUI [2,1]
C0024301
UMLS CUI [2,2]
C0432516
have no prior systemic treatment for lymphoma
Beschreibung

Systemic therapy Absent Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0024299
symptomatic follicular lymphoma requiring treatment.
Beschreibung

Follicular Lymphoma Symptomatic Treatment required for

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C0332121
age ≥18 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
eastern cooperative oncology group performance status 0-2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
willing to follow pregnancy precautions
Beschreibung

Contraceptive methods Willing

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinical evidence of transformed lymphoma or grade 3b follicular lymphoma.
Beschreibung

Lymphoma transformation | Follicular Lymphoma Grade

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0040682
UMLS CUI [2,1]
C0024301
UMLS CUI [2,2]
C0441800
major surgery (excluding lymph node biopsy) within 28 days prior to signing informed consent.
Beschreibung

Major surgery | Exception Biopsy of lymph node

Datentyp

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0193842
known seropositive for or active viral infection with hepatitis b virus (hbv), hepatitis c virus (hcv), human immunodeficiency virus (hiv)
Beschreibung

Serology positive Hepatitis B | Serology positive Hepatitis C | HIV Seropositivity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0242089
UMLS CUI [1,2]
C0019163
UMLS CUI [2,1]
C0242089
UMLS CUI [2,2]
C0019196
UMLS CUI [3]
C0019699
known sensitivity or allergy to murine products.
Beschreibung

Hypersensitivity Product Murine

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1254351
UMLS CUI [1,3]
C0026809
presence or history of central nervous system involvement by lymphoma
Beschreibung

Central Nervous System Involvement Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0024299
at high risk for a venous thromboembolic event (vte) and not willing to take vte prophylaxis
Beschreibung

High risk of Venous Thromboembolism | Prophylactic treatment Unwilling Venous Thromboembolism

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C1861172
UMLS CUI [2,1]
C0199176
UMLS CUI [2,2]
C0558080
UMLS CUI [2,3]
C1861172
any of the following laboratory abnormalities:
Beschreibung

LABORATORY ABNORMALITIES

Datentyp

boolean

Alias
UMLS CUI [1]
C1853129
serum aspartate transaminase or alanine transaminase > 3x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma
Beschreibung

Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
total bilirubin > 2.0 mg/dl (34 µmol/l) except in cases of gilberts syndrome and documented liver or pancreatic involvement by lymphoma
Beschreibung

Serum total bilirubin measurement | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma | Exception Pancreas Involvement with Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0017551
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0030274
UMLS CUI [4,3]
C1314939
UMLS CUI [4,4]
C0024299
creatinine clearance of < 30 ml/min
Beschreibung

Creatinine clearance measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0373595
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Follicular Lymphoma NCT01476787

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Follicular Lymphoma Grade | Follicular Lymphoma Ann Arbor lymphoma staging system
Item
histologically confirmed follicular lymphoma grade 1, 2 or 3a, stage ii-iv
boolean
C0024301 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0024301 (UMLS CUI [2,1])
C0432516 (UMLS CUI [2,2])
Systemic therapy Absent Lymphoma
Item
have no prior systemic treatment for lymphoma
boolean
C1515119 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
Follicular Lymphoma Symptomatic Treatment required for
Item
symptomatic follicular lymphoma requiring treatment.
boolean
C0024301 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0332121 (UMLS CUI [1,3])
Age
Item
age ≥18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Contraceptive methods Willing
Item
willing to follow pregnancy precautions
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Lymphoma transformation | Follicular Lymphoma Grade
Item
clinical evidence of transformed lymphoma or grade 3b follicular lymphoma.
boolean
C0024299 (UMLS CUI [1,1])
C0040682 (UMLS CUI [1,2])
C0024301 (UMLS CUI [2,1])
C0441800 (UMLS CUI [2,2])
Major surgery | Exception Biopsy of lymph node
Item
major surgery (excluding lymph node biopsy) within 28 days prior to signing informed consent.
boolean
C0679637 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0193842 (UMLS CUI [2,2])
Serology positive Hepatitis B | Serology positive Hepatitis C | HIV Seropositivity
Item
known seropositive for or active viral infection with hepatitis b virus (hbv), hepatitis c virus (hcv), human immunodeficiency virus (hiv)
boolean
C0242089 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0242089 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C0019699 (UMLS CUI [3])
Hypersensitivity Product Murine
Item
known sensitivity or allergy to murine products.
boolean
C0020517 (UMLS CUI [1,1])
C1254351 (UMLS CUI [1,2])
C0026809 (UMLS CUI [1,3])
Central Nervous System Involvement Lymphoma
Item
presence or history of central nervous system involvement by lymphoma
boolean
C4050309 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
High risk of Venous Thromboembolism | Prophylactic treatment Unwilling Venous Thromboembolism
Item
at high risk for a venous thromboembolic event (vte) and not willing to take vte prophylaxis
boolean
C0332167 (UMLS CUI [1,1])
C1861172 (UMLS CUI [1,2])
C0199176 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
C1861172 (UMLS CUI [2,3])
LABORATORY ABNORMALITIES
Item
any of the following laboratory abnormalities:
boolean
C1853129 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma
Item
serum aspartate transaminase or alanine transaminase > 3x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
Serum total bilirubin measurement | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma | Exception Pancreas Involvement with Lymphoma
Item
total bilirubin > 2.0 mg/dl (34 µmol/l) except in cases of gilberts syndrome and documented liver or pancreatic involvement by lymphoma
boolean
C1278039 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0017551 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
C1705847 (UMLS CUI [4,1])
C0030274 (UMLS CUI [4,2])
C1314939 (UMLS CUI [4,3])
C0024299 (UMLS CUI [4,4])
Creatinine clearance measurement
Item
creatinine clearance of < 30 ml/min
boolean
C0373595 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video